Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 May 1;315(Pt 3):833–844. doi: 10.1042/bj3150833

Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy.

K D O'Neal 1, M V Chari 1, C H Mcdonald 1, R G Cook 1, L Y Yu-Lee 1, J D Morrisett 1, W T Shearer 1
PMCID: PMC1217282  PMID: 8645165

Abstract

An eight-amino-acid synthetic peptide (IIe1-Phe2-Pro3-Pro4-Val5-Pro6-Gly7-Pro8) corresponding to the conserved proline-rich motif (PRM) of the intracellular domain of the prolactin receptor (PRL-R) was studied by one- and two-dimensional (1D and 2D) proton NMR spectroscopy in water and DMSO in order to characterize its conformational dynamics. The purified PRL-R PRM peptide eluted as two partially resolved peaks in equilibrium on reverse-phase HPLC (RP-HPLC) at 20 degrees C with a ratio of 60:40. At 30 degrees C, the two peaks coalesced into a single peak The two RP-HPLC peaks correspond to two peptide conformers resulting from the slow cis-trans isomerization of one of the four proline amide bonds. Although the peptide has only three amide (NH) protons, its ID NMR spectrum in water contains approximately 15 discernible NH region peaks, providing evidence for multiple conformers. The amide resonances were assigned on the basis of 2D-COSY spectra, chemical shift values resonance splitting patterns and temperature coefficients. The cis:trans ratio for each proline in water, calculated from integrated intensities and/or peak heights of the appropriate resonances, were Phe2-Pro3 (35:65), Pro3-Pro4 (40:60), Val5-Pro6 (70:30), and Gly7-Pro8 (30:70). Temperature studies (25-70 degrees C) were used to semi-quantitatively estimate the rates of isomerization for the different prolines. In water, Pro8 undergoes rapid isomerization; Pro3 isomerizes at an intermediate rate; while Pro4 and Pro6 both appear to isomerize very slowly since no coalescence of amide resonances was observed. In DMSO, only Pro4 displayed slow isomerization. Slow kinetics combined with a similar 60:40 ratio of conformers determined by RP-HPLC and NMR suggests that isomerization of the Pro3-Pro4 bond generates the two RP-HPLC peaks. Both proximal and distal proline isomerization effects were observed in NMR experiments. All of the 16 theoretical (24 = 16) proline configurations appear to exist in equilibrium in water The predominant (19%) conformation, trans3-trans4-cis6-trans8, may reflect the configuration of the PRM prolines in the native PRL-R. Isomerization of Pro6 from cis to trans generates an interaction between the peptide N-and C-termini, suggesting an overall pseudo-cyclic conformation. This all-trans proline configuration may play an important biochemical role in the function of cytokine/haematopoietin receptors. A model is proposed which suggests that isomerization of the PRM by an immunophilin such as the FK 506-binding protein (FKBP) serves as an on-off switch for cytokine receptor activation.

Full Text

The Full Text of this article is available as a PDF (769.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adzhubei A. A., Sternberg M. J. Left-handed polyproline II helices commonly occur in globular proteins. J Mol Biol. 1993 Jan 20;229(2):472–493. doi: 10.1006/jmbi.1993.1047. [DOI] [PubMed] [Google Scholar]
  2. Ali S., Edery M., Pellegrini I., Lesueur L., Paly J., Djiane J., Kelly P. A. The Nb2 form of prolactin receptor is able to activate a milk protein gene promoter. Mol Endocrinol. 1992 Aug;6(8):1242–1248. doi: 10.1210/mend.6.8.1406702. [DOI] [PubMed] [Google Scholar]
  3. Arad O., Goodman M. Depsipeptide analogues of elastin repeating sequences: conformational analysis. Biopolymers. 1990 Oct-Nov;29(12-13):1652–1668. doi: 10.1002/bip.360291213. [DOI] [PubMed] [Google Scholar]
  4. Baumann H., Symes A. J., Comeau M. R., Morella K. K., Wang Y., Friend D., Ziegler S. F., Fink J. S., Gearing D. P. Multiple regions within the cytoplasmic domains of the leukemia inhibitory factor receptor and gp130 cooperate in signal transduction in hepatic and neuronal cells. Mol Cell Biol. 1994 Jan;14(1):138–146. doi: 10.1128/mcb.14.1.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bazan J. F. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem Biophys Res Commun. 1989 Oct 31;164(2):788–795. doi: 10.1016/0006-291x(89)91528-3. [DOI] [PubMed] [Google Scholar]
  6. Brandts J. F., Halvorson H. R., Brennan M. Consideration of the Possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. Biochemistry. 1975 Nov 4;14(22):4953–4963. doi: 10.1021/bi00693a026. [DOI] [PubMed] [Google Scholar]
  7. Brillantes A. B., Ondrias K., Scott A., Kobrinsky E., Ondriasová E., Moschella M. C., Jayaraman T., Landers M., Ehrlich B. E., Marks A. R. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell. 1994 May 20;77(4):513–523. doi: 10.1016/0092-8674(94)90214-3. [DOI] [PubMed] [Google Scholar]
  8. Brizzi M. F., Zini M. G., Aronica M. G., Blechman J. M., Yarden Y., Pegoraro L. Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinase. J Biol Chem. 1994 Dec 16;269(50):31680–31684. [PubMed] [Google Scholar]
  9. Cameron A. M., Steiner J. P., Sabatini D. M., Kaplin A. I., Walensky L. D., Snyder S. H. Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1784–1788. doi: 10.1073/pnas.92.5.1784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Campbell G. S., Argetsinger L. S., Ihle J. N., Kelly P. A., Rillema J. A., Carter-Su C. Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5232–5236. doi: 10.1073/pnas.91.12.5232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chazin W. J., Kördel J., Drakenberg T., Thulin E., Brodin P., Grundström T., Forsén S. Proline isomerism leads to multiple folded conformations of calbindin D9k: direct evidence from two-dimensional 1H NMR spectroscopy. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2195–2198. doi: 10.1073/pnas.86.7.2195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cicchetti P., Mayer B. J., Thiel G., Baltimore D. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science. 1992 Aug 7;257(5071):803–806. doi: 10.1126/science.1379745. [DOI] [PubMed] [Google Scholar]
  13. Darnell J. E., Jr, Kerr I. M., Stark G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994 Jun 3;264(5164):1415–1421. doi: 10.1126/science.8197455. [DOI] [PubMed] [Google Scholar]
  14. Davis S., Aldrich T. H., Stahl N., Pan L., Taga T., Kishimoto T., Ip N. Y., Yancopoulos G. D. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science. 1993 Jun 18;260(5115):1805–1808. doi: 10.1126/science.8390097. [DOI] [PubMed] [Google Scholar]
  15. Dyson H. J., Rance M., Houghten R. A., Lerner R. A., Wright P. E. Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn. J Mol Biol. 1988 May 5;201(1):161–200. doi: 10.1016/0022-2836(88)90446-9. [DOI] [PubMed] [Google Scholar]
  16. Elberg G., Kelly P. A., Djiane J., Binder L., Gertler A. Mitogenic and binding properties of monoclonal antibodies to the prolactin receptor in Nb2 rat lymphoma cells. Selective enhancement by anti-mouse IgG. J Biol Chem. 1990 Sep 5;265(25):14770–14776. [PubMed] [Google Scholar]
  17. Fontenot J. D., Finn O. J., Dales N., Andrews P. C., Montelaro R. C. Synthesis of large multideterminant peptide immunogens using a poly-proline beta-turn helix motif. Pept Res. 1993 Nov-Dec;6(6):330–336. [PubMed] [Google Scholar]
  18. Frank S. J., Gilliland G., Kraft A. S., Arnold C. S. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology. 1994 Nov;135(5):2228–2239. doi: 10.1210/endo.135.5.7956946. [DOI] [PubMed] [Google Scholar]
  19. Fukunaga R., Ishizaka-Ikeda E., Nagata S. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell. 1993 Sep 24;74(6):1079–1087. doi: 10.1016/0092-8674(93)90729-a. [DOI] [PubMed] [Google Scholar]
  20. Gething M. J., Sambrook J. Protein folding in the cell. Nature. 1992 Jan 2;355(6355):33–45. doi: 10.1038/355033a0. [DOI] [PubMed] [Google Scholar]
  21. Goldsmith M. A., Xu W., Amaral M. C., Kuczek E. S., Greene W. C. The cytoplasmic domain of the interleukin-2 receptor beta chain contains both unique and functionally redundant signal transduction elements. J Biol Chem. 1994 May 20;269(20):14698–14704. [PubMed] [Google Scholar]
  22. Goujon L., Allevato G., Simonin G., Paquereau L., Le Cam A., Clark J., Nielsen J. H., Djiane J., Postel-Vinay M. C., Edery M. Cytoplasmic sequences of the growth hormone receptor necessary for signal transduction. Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):957–961. doi: 10.1073/pnas.91.3.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Harrison R. K., Stein R. L. Mechanistic studies of peptidyl prolyl cis-trans isomerase: evidence for catalysis by distortion. Biochemistry. 1990 Feb 20;29(7):1684–1689. doi: 10.1021/bi00459a003. [DOI] [PubMed] [Google Scholar]
  24. Helekar S. A., Char D., Neff S., Patrick J. Prolyl isomerase requirement for the expression of functional homo-oligomeric ligand-gated ion channels. Neuron. 1994 Jan;12(1):179–189. doi: 10.1016/0896-6273(94)90162-7. [DOI] [PubMed] [Google Scholar]
  25. Henderson D. E., Mello J. A. Physicochemical studies of biologically active peptides by low-temperature reversed-phase high-performance liquid chromatography. J Chromatogr. 1990 Jan 19;499:79–88. doi: 10.1016/s0021-9673(00)96965-6. [DOI] [PubMed] [Google Scholar]
  26. Hooper K. P., Padmanabhan R., Ebner K. E. Expression of the extracellular domain of the rat liver prolactin receptor and its interaction with ovine prolactin. J Biol Chem. 1993 Oct 25;268(30):22347–22352. [PubMed] [Google Scholar]
  27. Ihle J. N., Witthuhn B. A., Quelle F. W., Yamamoto K., Thierfelder W. E., Kreider B., Silvennoinen O. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci. 1994 May;19(5):222–227. doi: 10.1016/0968-0004(94)90026-4. [DOI] [PubMed] [Google Scholar]
  28. Johnson W. C., Jr Protein secondary structure and circular dichroism: a practical guide. Proteins. 1990;7(3):205–214. doi: 10.1002/prot.340070302. [DOI] [PubMed] [Google Scholar]
  29. Kördel J., Forsén S., Drakenberg T., Chazin W. J. The rate and structural consequences of proline cis-trans isomerization in calbindin D9k: NMR studies of the minor (cis-Pro43) isoform and the Pro43Gly mutant. Biochemistry. 1990 May 8;29(18):4400–4409. doi: 10.1021/bi00470a020. [DOI] [PubMed] [Google Scholar]
  30. Lebrun J. J., Ali S., Sofer L., Ullrich A., Kelly P. A. Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J Biol Chem. 1994 May 13;269(19):14021–14026. [PubMed] [Google Scholar]
  31. Lebrun J. J., Ali S., Ullrich A., Kelly P. A. Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. J Biol Chem. 1995 May 5;270(18):10664–10670. doi: 10.1074/jbc.270.18.10664. [DOI] [PubMed] [Google Scholar]
  32. Lim W. A., Richards F. M., Fox R. O. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature. 1994 Nov 24;372(6504):375–379. doi: 10.1038/372375a0. [DOI] [PubMed] [Google Scholar]
  33. MacArthur M. W., Thornton J. M. Influence of proline residues on protein conformation. J Mol Biol. 1991 Mar 20;218(2):397–412. doi: 10.1016/0022-2836(91)90721-h. [DOI] [PubMed] [Google Scholar]
  34. Madison V., Schellman J. Location of proline derivatives in conformational space. I. Conformational calculations; optical activity and NMR experiments. Biopolymers. 1970;9(5):511–567. doi: 10.1002/bip.1970.360090502. [DOI] [PubMed] [Google Scholar]
  35. Murakami M., Narazaki M., Hibi M., Yawata H., Yasukawa K., Hamaguchi M., Taga T., Kishimoto T. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11349–11353. doi: 10.1073/pnas.88.24.11349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mücke M., Schmid F. X. Folding mechanism of ribonuclease T1 in the absence of the disulfide bonds. Biochemistry. 1994 Dec 6;33(48):14608–14619. doi: 10.1021/bi00252a029. [DOI] [PubMed] [Google Scholar]
  37. Nakamura Y., Russell S. M., Mess S. A., Friedmann M., Erdos M., Francois C., Jacques Y., Adelstein S., Leonard W. J. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature. 1994 May 26;369(6478):330–333. doi: 10.1038/369330a0. [DOI] [PubMed] [Google Scholar]
  38. O'Neal K. D., Shearer W. T. Clarification of the role of the Pro-X-Pro sequence in interleukin-5 receptor signal transduction. Mol Cell Biol. 1995 Aug;15(8):4657–4658. doi: 10.1128/mcb.15.8.4657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. O'Neal K. D., Yu-Lee L. Y. Differential signal transduction of the short, Nb2, and long prolactin receptors. Activation of interferon regulatory factor-1 and cell proliferation. J Biol Chem. 1994 Oct 21;269(42):26076–26082. [PubMed] [Google Scholar]
  40. O'Neal K. D., Yu-Lee L. Y., Shearer W. T. The proline-rich motif is necessary but not sufficient for prolactin receptor signal transduction. Ann N Y Acad Sci. 1995 Sep 7;766:282–284. doi: 10.1111/j.1749-6632.1995.tb26677.x. [DOI] [PubMed] [Google Scholar]
  41. O'Neal K. D., Yu-Lee L. Y. The proline-rich motif (PRM): a novel feature of the cytokine/hematopoietin receptor superfamily. Lymphokine Cytokine Res. 1993 Oct;12(5):309–312. [PubMed] [Google Scholar]
  42. Pogliani L., Ellenberger M., Valat J., Bellocq A. M. NMR investigations of proline and its derivatives. 4-Proton magnetic resonance parameters and structure of acetyl-proline amide. Int J Pept Protein Res. 1975;7(5):345–360. [PubMed] [Google Scholar]
  43. Poznański J., Ejchart A., Wierzchowski K. L., Ciurak M. 1H- and 13C-NMR investigations on cis-trans isomerization of proline peptide bonds and conformation of aromatic side chains in H-Trp-(Pro)n-Tyr-OH peptides. Biopolymers. 1993 May;33(5):781–795. doi: 10.1002/bip.360330507. [DOI] [PubMed] [Google Scholar]
  44. Ren R., Mayer B. J., Cicchetti P., Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science. 1993 Feb 19;259(5098):1157–1161. doi: 10.1126/science.8438166. [DOI] [PubMed] [Google Scholar]
  45. Rui H., Kirken R. A., Farrar W. L. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem. 1994 Feb 18;269(7):5364–5368. [PubMed] [Google Scholar]
  46. Sakamaki K., Miyajima I., Kitamura T., Miyajima A. Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J. 1992 Oct;11(10):3541–3549. doi: 10.1002/j.1460-2075.1992.tb05437.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Schreiber S. L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 1991 Jan 18;251(4991):283–287. doi: 10.1126/science.1702904. [DOI] [PubMed] [Google Scholar]
  48. Schreiber S. L. Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell. 1992 Aug 7;70(3):365–368. doi: 10.1016/0092-8674(92)90158-9. [DOI] [PubMed] [Google Scholar]
  49. Sehgal S. N., Bansbach C. C. Rapamycin: in vitro profile of a new immunosuppressive macrolide. Ann N Y Acad Sci. 1993 Jun 23;685:58–67. doi: 10.1111/j.1749-6632.1993.tb35852.x. [DOI] [PubMed] [Google Scholar]
  50. Smith J. A., Pease L. G. Reverse turns in peptides and proteins. CRC Crit Rev Biochem. 1980;8(4):315–399. doi: 10.3109/10409238009105470. [DOI] [PubMed] [Google Scholar]
  51. Steinmetz W. E., Bianco T. I., Zollinger M., Pesiri D. Characterization of the multiple forms of mast cell degranulating peptide by NMR spectroscopy. Pept Res. 1994 Mar-Apr;7(2):77–82. [PubMed] [Google Scholar]
  52. Svensson L. A., Thulin E., Forsén S. Proline cis-trans isomers in calbindin D9k observed by X-ray crystallography. J Mol Biol. 1992 Feb 5;223(3):601–606. doi: 10.1016/0022-2836(92)90976-q. [DOI] [PubMed] [Google Scholar]
  53. Takaki S., Kanazawa H., Shiiba M., Takatsu K. A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor alpha chain and its function in IL-5-mediated growth signal transduction. Mol Cell Biol. 1994 Nov;14(11):7404–7413. doi: 10.1128/mcb.14.11.7404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science. 1995 Apr 14;268(5208):251–255. doi: 10.1126/science.7716517. [DOI] [PubMed] [Google Scholar]
  55. Van Duyne G. D., Standaert R. F., Karplus P. A., Schreiber S. L., Clardy J. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science. 1991 May 10;252(5007):839–842. doi: 10.1126/science.1709302. [DOI] [PubMed] [Google Scholar]
  56. VanderKuur J. A., Wang X., Zhang L., Campbell G. S., Allevato G., Billestrup N., Norstedt G., Carter-Su C. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase. J Biol Chem. 1994 Aug 26;269(34):21709–21717. [PubMed] [Google Scholar]
  57. Veeraraghavan S., Nall B. T. Characterization of folding intermediates using prolyl isomerase. Biochemistry. 1994 Jan 25;33(3):687–692. doi: 10.1021/bi00169a009. [DOI] [PubMed] [Google Scholar]
  58. Viguera A. R., Arrondo J. L., Musacchio A., Saraste M., Serrano L. Characterization of the interaction of natural proline-rich peptides with five different SH3 domains. Biochemistry. 1994 Sep 13;33(36):10925–10933. doi: 10.1021/bi00202a011. [DOI] [PubMed] [Google Scholar]
  59. Wang T., Donahoe P. K., Zervos A. S. Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12. Science. 1994 Jul 29;265(5172):674–676. doi: 10.1126/science.7518616. [DOI] [PubMed] [Google Scholar]
  60. Wang Y. D., Wood W. I. Amino acids of the human growth hormone receptor that are required for proliferation and Jak-STAT signaling. Mol Endocrinol. 1995 Mar;9(3):303–311. doi: 10.1210/mend.9.3.7539888. [DOI] [PubMed] [Google Scholar]
  61. Watling D., Guschin D., Müller M., Silvennoinen O., Witthuhn B. A., Quelle F. W., Rogers N. C., Schindler C., Stark G. R., Ihle J. N. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature. 1993 Nov 11;366(6451):166–170. doi: 10.1038/366166a0. [DOI] [PubMed] [Google Scholar]
  62. Watowich S. S., Hilton D. J., Lodish H. F. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol Cell Biol. 1994 Jun;14(6):3535–3549. doi: 10.1128/mcb.14.6.3535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wilmot C. M., Thornton J. M. Analysis and prediction of the different types of beta-turn in proteins. J Mol Biol. 1988 Sep 5;203(1):221–232. doi: 10.1016/0022-2836(88)90103-9. [DOI] [PubMed] [Google Scholar]
  64. Wüthrich K. Protein structure determination in solution by nuclear magnetic resonance spectroscopy. Science. 1989 Jan 6;243(4887):45–50. doi: 10.1126/science.2911719. [DOI] [PubMed] [Google Scholar]
  65. Yu H., Chen J. K., Feng S., Dalgarno D. C., Brauer A. W., Schreiber S. L. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell. 1994 Mar 11;76(5):933–945. doi: 10.1016/0092-8674(94)90367-0. [DOI] [PubMed] [Google Scholar]
  66. Yu H., Rosen M. K., Shin T. B., Seidel-Dugan C., Brugge J. S., Schreiber S. L. Solution structure of the SH3 domain of Src and identification of its ligand-binding site. Science. 1992 Dec 4;258(5088):1665–1668. doi: 10.1126/science.1280858. [DOI] [PubMed] [Google Scholar]
  67. Ziemiecki A., Harpur A. G., Wilks A. F. JAK protein tyrosine kinases: their role in cytokine signalling. Trends Cell Biol. 1994 Jun;4(6):207–212. doi: 10.1016/0962-8924(94)90143-0. [DOI] [PubMed] [Google Scholar]
  68. de Vos A. M., Ultsch M., Kossiakoff A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 1992 Jan 17;255(5042):306–312. doi: 10.1126/science.1549776. [DOI] [PubMed] [Google Scholar]
  69. von Heijne G. Proline kinks in transmembrane alpha-helices. J Mol Biol. 1991 Apr 5;218(3):499–503. doi: 10.1016/0022-2836(91)90695-3. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES